Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
HyperScribe T7 High Yield Cy5 RNA Labeling Kit: Optimizing F
2026-05-09
The HyperScribe T7 High Yield Cy5 RNA Labeling Kit empowers researchers to achieve robust, high-yield fluorescent RNA probe synthesis tailored for sensitive applications like in situ and Northern blot hybridizations. Its tunable Cy5-UTP incorporation and comprehensive workflow support ensure reproducibility and precision for advanced RNA detection.
-
Optimizing Cell Assays with SU5416 (Semaxanib): Practical So
2026-05-09
This article provides evidence-based guidance for using SU5416 (Semaxanib), SKU A3847, to overcome common laboratory challenges in cell viability, proliferation, and angiogenesis assays. Drawing from recent literature and practical workflow insights, it addresses experimental design, data interpretation, and product reliability, positioning SU5416 as a robust solution for advanced cancer and immunology research.
-
Praeruptorin A: Mechanistic Advances in Metastasis and Infla
2026-05-08
Explore Praeruptorin A, an angular pyranocoumarin compound, and its advanced anti-metastatic and anti-inflammatory mechanisms. This article offers a unique, mechanistic analysis for researchers seeking deeper insight into ferroptosis inhibition and hepatocellular carcinoma.
-
Latrunculin A: Reversible Inhibitor of Actin Assembly in App
2026-05-07
Latrunculin A, a reversible inhibitor of actin assembly from APExBIO, empowers cell biologists to precisely dissect cytoskeletal dynamics, morphogenesis, and host-pathogen interactions. This guide translates the latest viral pathogenesis insights into actionable, reproducible workflows and troubleshooting strategies for advanced research.
-
Calpain Inhibitor I, ALLN: Protocols and Best Practices
2026-05-07
Calpain Inhibitor I, ALLN enables precise inhibition of calpain and cathepsin proteases in apoptosis, inflammation, and ischemia-reperfusion injury models. It is designed for research use only and should not be used in diagnostic or clinical workflows. This guide details actionable protocols, troubleshooting, and limitations for optimal use.
-
PNU 74654: Precision Wnt Signaling Pathway Inhibitor Workflo
2026-05-06
PNU 74654 stands out as a high-purity Wnt signaling pathway inhibitor, enabling robust, reproducible modulation of the Wnt/β-catenin axis for cancer and stem cell research. This guide translates mechanistic insights and recent advances into actionable protocols, advanced troubleshooting, and comparative applications that maximize assay performance.
-
Alternariol in Mycotoxin Research: Protocols and Pitfalls
2026-05-06
Alternariol (AOH) is revolutionizing mycotoxin research by enabling precise modeling of hepatotoxicity and apoptosis pathways. This article translates cutting-edge mechanistic findings into actionable workflows and troubleshooting strategies for advanced cellular, enzymatic, and omics-based assays.
-
Machine Learning Unlocks New Senolytics: Focus on Cardiac Gl
2026-05-05
This article examines the innovative machine learning approach used to discover new senolytics, as detailed in Smer-Barreto et al. (2023). The work highlights the identification of cardiac glycosides, including ouabain, as potent, cell-type selective senolytic agents, with implications for aging and disease research.
-
HyperScript™ Reverse Transcriptase: cDNA Synthesis for qPCR
2026-05-05
HyperScript™ Reverse Transcriptase, engineered from M-MLV Reverse Transcriptase, enables efficient cDNA synthesis from RNA templates with complex secondary structure. Its enhanced thermal stability and low RNase H activity allow for reliable RNA to cDNA conversion in demanding molecular biology applications.
-
X-ray-Triggered Nanomicelles for Nuclear DOX Release in Chem
2026-05-04
Yao et al. developed a nanomicelle platform enabling X-ray-induced, Cherenkov-light-triggered release of caged doxorubicin directly into cell nuclei. This innovation enables precise chemoradiation activation, achieving tumor eradication with minimal off-target toxicity and providing a new paradigm in localized cancer therapy.
-
Bay 11-7821 (BAY 11-7082): Precision NF-κB Inhibition in Res
2026-05-04
Bay 11-7821 (BAY 11-7082) is a gold-standard tool for dissecting NF-κB-driven inflammatory and apoptotic processes, offering reproducible results in both in vitro and in vivo models. Its unique selectivity and workflow flexibility make it indispensable for inflammatory signaling pathway research, apoptosis studies, and cancer biology.
-
O-GlcNAcylation Regulates Ferroptosis in Preeclampsia via HU
2026-05-03
This study reveals that O-GlcNAc modification of HUWE1 orchestrates ubiquitination of transferrin receptor 1 (TfR1), regulating ferroptosis and trophoblast syncytialization in preeclampsia. The findings advance understanding of placental oxidative stress mechanisms and suggest that targeting the O-GlcNAc-HUWE1-TfR1 pathway may offer new therapeutic strategies in preeclampsia management.
-
Dimethyloxalylglycine (DMOG): Technical Guidance for Hypoxia
2026-05-02
Dimethyloxalylglycine (DMOG) provides a robust approach for stabilizing hypoxia-inducible factors and modeling hypoxic signaling in both in vitro and in vivo settings. This product is best used for mechanistic studies of oxygen sensing, immune modulation, and inflammation pathways, but is not suitable for diagnostic or clinical applications.
-
Bardoxolone Methyl in Redox Modulation: Protocols & Applicat
2026-05-02
Bardoxolone methyl (CDDO methyl ester) is a powerful modulator of the Nrf2 and NF-kB pathways, enabling precise studies of oxidative stress and inflammation. This guide translates high-impact redox research into actionable protocols, troubleshooting strategies, and advanced applications for cancer and kidney disease models.
-
LG 101506: Synthetic RXR Modulator for Nuclear Receptor Rese
2026-05-01
LG 101506 is a high-purity RXR modulator used in nuclear receptor signaling studies. It enables precise interrogation of RXR biology and immuno-metabolic pathways, with validated stability and solubility parameters. APExBIO supplies LG 101506 (B7414) for research-only use.